CareDx To Participate in Upcoming Jefferies Healthcare Conference
CareDx To Participate in Upcoming Jefferies Healthcare Conference
CareDx, Inc. (Nasdaq: CDNA), a leader in precision medicine for transplant patients, will participate in the Jefferies Healthcare Conference on June 9, 2022, at 2:00 PM ET.
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--
CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the Company will participate in the Jefferies Healthcare Conference on June 9th, 2022.
CareDx’s management is scheduled to present at the Jefferies Healthcare Conference on Thursday, June 9th, 2022, at 2:00 PM ET. To listen to the webcast, please visit the investor relations section of CareDx’s website at: investors.caredxinc.com.
About CareDx – The Transplant Company
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.
